| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| P E Gottschall, J Meite. Bromocryptine prevents the decline in tuberoinfundibular neuronal release of dopamine after removal of chronic estrogen treatment. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.). vol 186. issue 2. 1987-11-25. PMID:3671354. |
prolonged exposure to estradiol 17-beta (e2) in rats has been shown to decrease dopamine (da) synthesis in and release from tuberoinfundibular dopaminergic (tida) neurons in fischer 344 rats. |
1987-11-25 |
2023-08-11 |
rat |
| C Decavel, L Lescaudron, N Mons, A Cala. First visualization of dopaminergic neurons with a monoclonal antibody to dopamine: a light and electron microscopic study. The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society. vol 35. issue 11. 1987-11-20. PMID:3309046. |
first visualization of dopaminergic neurons with a monoclonal antibody to dopamine: a light and electron microscopic study. |
1987-11-20 |
2023-08-11 |
mouse |
| U K Rinne, J O Rinne, J K Rinne, K Laaks. Chemical neurotransmission in the parkinsonian brain. Medical biology. vol 65. issue 2-3. 1987-11-19. PMID:2821331. |
the findings concerning dopamine receptors both in vitro and in vivo are not consistent, possibly reflecting differences in patient populations, but the presynaptic defect in dopaminergic neurotransmission is greater than that seen in postsynaptic receptor binding studies. |
1987-11-19 |
2023-08-11 |
Not clear |
| b' P T M\\xc3\\xa4nnist\\xc3\\xb. Aminergic regulation of neuroendocrinological functions: theoretical background and some clinical examples. Medical biology. vol 65. issue 2-3. 1987-11-19. PMID:2888929.' |
expectedly, dopaminergic drugs (bromocryptine, lergotrile, piribedil, dopamine and levodopa) are quite effective in reducing high prolactin levels regardless of the reason. |
1987-11-19 |
2023-08-11 |
Not clear |
| W Koller, G Herbster, D Anderson, R Wack, J Gordo. Quinpirole hydrochloride, a potential anti-parkinsonism drug. Neuropharmacology. vol 26. issue 8. 1987-11-18. PMID:3309709. |
quinpirole hydrochloride, a putative dopamine agonist, was investigated in animal models of central dopaminergic activity, to evaluate its possible role in the treatment of parkinson's disease. |
1987-11-18 |
2023-08-11 |
rat |
| G B Stefano, E Braham, P Finn, E Aiello, M K Leun. Aging alterations in the modulation of central dopaminergic cilioinhibition by etorphine in the marine mussel, Mytilus edulis: decrease in the inhibition of presynaptic dopamine release. Cellular and molecular neurobiology. vol 7. issue 2. 1987-11-16. PMID:3652116. |
aging alterations in the modulation of central dopaminergic cilioinhibition by etorphine in the marine mussel, mytilus edulis: decrease in the inhibition of presynaptic dopamine release. |
1987-11-16 |
2023-08-11 |
Not clear |
| G B Stefano, E Braham, P Finn, E Aiello, M K Leun. Aging alterations in the modulation of central dopaminergic cilioinhibition by etorphine in the marine mussel, Mytilus edulis: decrease in the inhibition of presynaptic dopamine release. Cellular and molecular neurobiology. vol 7. issue 2. 1987-11-16. PMID:3652116. |
in older animals cilioinhibition has become enhanced due to a lack of responsiveness to endogenous opioids which results in greater dopamine release, causing a higher level of cilioinhibition as demonstrated by challenging the visceral ganglia with etorphine or destroying the dopaminergic component with 6-hydroxydopamine. |
1987-11-16 |
2023-08-11 |
Not clear |
| J A Martínez, M L Vargas, M V Milané. [Interaction of opioid peptides and the dopaminergic system in the myenteric plexus of the guniea pig ileum]. Revista espanola de fisiologia. vol 43. issue 2. 1987-11-09. PMID:3116617. |
these findings indicate that interruption of dopaminergic transmission in the myenteric plexus produces an increase in the release of opioid peptides and suggest an inhibitory modulation of opioid peptidergic neurons by dopamine systems in the myenteric plexus of the guinea-pig ileum. |
1987-11-09 |
2023-08-11 |
Not clear |
| H S Kim, S Iyengar, P L Woo. Reversal of the actions of morphine on mesocortical dopamine metabolism in the rat by the kappa agonist MR-2034: tentative mu-2 opioid control of mesocortical dopaminergic projections. Life sciences. vol 41. issue 14. 1987-10-30. PMID:2821337. |
reversal of the actions of morphine on mesocortical dopamine metabolism in the rat by the kappa agonist mr-2034: tentative mu-2 opioid control of mesocortical dopaminergic projections. |
1987-10-30 |
2023-08-11 |
rat |
| H S Kim, S Iyengar, P L Woo. Reversal of the actions of morphine on mesocortical dopamine metabolism in the rat by the kappa agonist MR-2034: tentative mu-2 opioid control of mesocortical dopaminergic projections. Life sciences. vol 41. issue 14. 1987-10-30. PMID:2821337. |
morphine was shown to enhance dopamine metabolism, as assessed by increased dihydroxyphenylacetic acid measurements, in the mesocortical dopaminergic projections of the rat (cingulate, pyriform and prefrontal cortices). |
1987-10-30 |
2023-08-11 |
rat |
| M Hadjiconstantinou, N H Nef. Is dopamine a transmitter in the periphery? Neuropharmacology. vol 26. issue 7B. 1987-10-29. PMID:2889155. |
this evidence includes identified and characterized dopaminergic receptors, the presence of relatively large concentrations of dopamine and dopac in some neurons and organ systems, and the differential loss of norepinephrine or dopamine following treatment with catecholaminergic neurotoxins. |
1987-10-29 |
2023-08-11 |
Not clear |
| M P Abbracchio, F Colombo, M Di Luca, P Zaratin, F Cattaben. Adenosine modulates the dopaminergic function in the nigro-striatal system by interacting with striatal dopamine dependent adenylate cyclase. Pharmacological research communications. vol 19. issue 4. 1987-10-29. PMID:2889222. |
adenosine modulates the dopaminergic function in the nigro-striatal system by interacting with striatal dopamine dependent adenylate cyclase. |
1987-10-29 |
2023-08-11 |
rat |
| M P Abbracchio, F Colombo, M Di Luca, P Zaratin, F Cattaben. Adenosine modulates the dopaminergic function in the nigro-striatal system by interacting with striatal dopamine dependent adenylate cyclase. Pharmacological research communications. vol 19. issue 4. 1987-10-29. PMID:2889222. |
r-pia, which interacts with both adenosine a1-inhibitory and a2-stimulatory receptors, dose-dependently inhibited the stimulation induced by dopamine, and seemed to utilize the same pool of enzyme linked to dopaminergic d1 receptors. |
1987-10-29 |
2023-08-11 |
rat |
| M P Abbracchio, F Colombo, M Di Luca, P Zaratin, F Cattaben. Adenosine modulates the dopaminergic function in the nigro-striatal system by interacting with striatal dopamine dependent adenylate cyclase. Pharmacological research communications. vol 19. issue 4. 1987-10-29. PMID:2889222. |
it is concluded that adenosine might modulate post-synaptic responses to dopamine via adenosine receptors which functionally interact with dopaminergic d1 receptors in striatum. |
1987-10-29 |
2023-08-11 |
rat |
| R E Hrusk. Influence of hypophysectomy on dopamine receptors and dopaminergic behaviors. Pharmacology, biochemistry, and behavior. vol 27. issue 4. 1987-10-29. PMID:3659087. |
influence of hypophysectomy on dopamine receptors and dopaminergic behaviors. |
1987-10-29 |
2023-08-11 |
rat |
| K R Evans, F J Vaccarin. Effects of d- and l-amphetamine on food intake: evidence for a dopaminergic substrate. Pharmacology, biochemistry, and behavior. vol 27. issue 4. 1987-10-29. PMID:3659091. |
since d- and l-amphetamine are equipotent at releasing noradrenaline, while d-amphetamine is 2 to 5 times more potent at releasing dopamine, the results suggest that d-amphetamine-induced feeding is associated with activation of a dopaminergic substrate. |
1987-10-29 |
2023-08-11 |
rat |
| R Sandyk, R P Iacono, C R Bamfor. The hypothalamus in Parkinson disease. Italian journal of neurological sciences. vol 8. issue 3. 1987-10-22. PMID:2887537. |
within this framework, the dopaminergic systems may be damaged, since striatal dopamine synthesis and receptor sensitivity have been shown to be regulated by acth and alpha-msh through direct arcuate nucleus-striatal projections. |
1987-10-22 |
2023-08-11 |
Not clear |
| M Yoshimura, S Kambara, H Okabayashi, H Takahashi, H Ijich. Effect of decreased dopamine synthesis on the development of hypertension induced by salt loading in spontaneously hypertensive rats. Clinical and experimental hypertension. Part A, Theory and practice. vol 9. issue 7. 1987-10-20. PMID:3621632. |
dopamine plays an important role in its protective action against the development of hypertension enhanced by salt loading, and decreased dopaminergic mechanisms accelerated hypertension in shr. |
1987-10-20 |
2023-08-11 |
rat |
| Y Hama, M Ebad. Characterization of [3H]cholecystokinin octapeptide binding to mouse brain synaptosomes: effects of neuroleptics. Neurochemical research. vol 12. issue 8. 1987-10-20. PMID:3627361. |
the presence of high concentrations of both dopamine and cholecystokinin (cck) in the striatum and in various limbic structures suggests that the cck may not only influence dopaminergic transmission, but it also may be relevant to the psychopathology of schizophrenia and to the therapeutic effects of neuroleptics. |
1987-10-20 |
2023-08-11 |
mouse |
| R Bugiardini, G Morgagni, A Pozzati, F Ottani, A Borghi, S Lenzi, P Pudd. Effect of oral levodopa and carbidopa on coronary spasm in variant angina pectoris. The American journal of cardiology. vol 60. issue 7. 1987-10-19. PMID:3630930. |
these findings are consistent with either a decreased central dopaminergic activity and associated disregulation of vasomotor tone, or a peripheral vasodilatory effect of increasing dopamine. |
1987-10-19 |
2023-08-11 |
Not clear |